DavisGL, CzajaAJ, TaswellHF, LudwigJ, GoVLW.Hepatitis B virus replication in steroid-treated severe HBsAg-positive chronic active hepatitis.Dig Dis Sci1985; 30: 97–103.
2.
ThalerH.Treatment of chronic active hepatitis-present state. The pros and cons of immunosuppressive therapy.Hepato-gastroenterol1984; 31: 6–11.
3.
CzajaAJ, LudwigJ, BaggenstossAH, WolfA.Corticosteroid-treated chronic active hepatitis in remission.N Engl J Med1981; 304: 5–9.
4.
SolowayRD, SummerskillWHJ, BaggenstossAHClinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis.Gastroenterology1972; 63: 820–33.
5.
SchalmSW, SummerskillWHJ, GitnickGL, ElvebackLR.Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis Bs antigen.Gut1987; 17: 781–6.
6.
LamKC, LaiCL, NgRP, TrepoC, WuPC.Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis.N Engl J Med1981; 304: 380–6.
7.
WuPC, LaiCL, LamKC, HoJ.Prednisolone in HBsAg-positive chronic active hepatitis: histological evaluation in a controlled prospective study.Hepatology1982; 2: 777–83.
8.
SagnelliE, PiccininoF, ManzilloGEffect of immunosuppressive therapy on HBsAg-positive chronic active hepatitis in relation to presence or absence of HBeAg and anti-HBe.Hepatology1983; 3: 690–5.
9.
SagnelliE, MaioG, FelacoFMSerum levels of hepatitis B surface and core antigens during immunosuppressive treatment of HBsAg-positive chronic active hepatitis.Lancet1980; 2: 395–7.
10.
ScullardGH, SmithCI, MeriganTC, RobinsonWS, GregoryPB.Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B.Gastroenterology1981; 81: 987–91.
11.
RakelaJ, RedekerAG, WelikyB.Effect of short-term prednisone therapy on aminotransferase levels and hepatitis B virus markers in chronic type B hepatitis.Gastroenterology1983; 84: 956–60.
12.
NairPV, TongMJ, StevensonD, RoskampD, BooneC.Effects of short-term, high dose prednisone treatment of patients with HBsAg-positive chronic active hepatitis.Liver1985; 5: 8–12.
13.
HoofnagleJG, DavisGL, PappasSCA short course of prednisolone in chronic type B hepatitis.Ann Intern Med1986; 104: 12–17.
14.
NowickiMJ, TongMJ, NairPV, StevensonD.Detection of anti-HBcIgM following prednisone treatment in patients with chronic active hepatitis B infection.Hepatology1984; 4: 1129–33.
15.
HansonRG, PetersMG, HoofnagleJH.Effects of immunosuppressive therapy with prednisolone on B and T lymphocyte function in patients with chronic type B hepatitis.Hepatology1986; 6: 173–9.
16.
HoofnagleJH, DusheikoGM, SeeffLB, JonesEA, WaggonerJG, BalesZB.Seroconversion from hepatitis B antigen to antibody in chronic type B hepatitis.Ann Intern Med1981; 94: 744–8.
17.
RealdiG, AlbertiA, RuggeMSeroconversion from hepatitis B antigen to antiHB in chronic hepatitis B viral infection.Gastroenterology1980; 79: 195–9.
18.
YokosukaO, OmataM, ImazekiFCombination of shortterm prednisolone and adenine arabinoside in the treatment of chronic hepatitis B.Gastroenterology1985; 89: 246–51.
19.
UribeM, GoVLM, KlugeD.Prednisone for chronic active hepatitis: pharmacokinetics and serum binding in patients with chronic active hepatitis and steroid major side effects.J Clin Gastroenterol1984; 6: 331–5.
